Trevi Therapeutics, Inc. · NASDAQ:TRVI
New Enterprise Associates 16, L.P. reported a 10.50% stake in Trevi Therapeutics, Inc. (Schedule 13D/A)
Event May 5, 2026 · Filed May 7, 2026
New Enterprise Associates 16, L.P. reported a 10.50% stake in Trevi Therapeutics, Inc., 15,074,080 shares, with active intent on May 5, 2026. Filed May 7, 2026 (Schedule 13D/A).
- Stake
- 10.50%
- Shares
- 15,074,080
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 13 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| New Enterprise Associates 16, L.P. | 10.50% | 15,074,080 |
| NEA Partners 16, L.P. | 10.50% | 15,074,080 |
| NEA 16 GP, LLC | 10.50% | 15,074,080 |
| NEA 18 Venture Growth Equity, L.P. | 10.50% | 15,074,080 |
| NEA Partners 18 VGE, L.P. | 10.50% | 15,074,080 |
| NEA 18 VGE GP, LLC | 10.50% | 15,074,080 |
| Forest Baskett | 9.80% | 14,125,132 |
| Ali Behbahani | 10.50% | 15,074,080 |
| Carmen Chang | 10.50% | 15,074,080 |
| Anthony A. Florence, Jr. | 10.50% | 15,074,080 |
| Mohamad H. Makhzoumi | 10.50% | 15,074,080 |
| Scott D. Sandell | 10.50% | 15,074,080 |
| Paul Walker | 10.50% | 15,074,080 |
Source
Related
- Trevi Therapeutics, Inc.
- New Enterprise Associates 16, L.P.
- Trevi Therapeutics, Inc. shareholders
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Feb 13, 2026
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Aug 11, 2025
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Mar 20, 2025
- Form 4 · Heffernan Michael Thomas · Sep 17, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · Rubric Capital Management LP · Feb 13, 2026